CAVALLO PERIN, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 13.527
EU - Europa 9.280
AS - Asia 3.372
SA - Sud America 106
OC - Oceania 84
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 12
Totale 26.437
Nazione #
US - Stati Uniti d'America 13.261
DK - Danimarca 3.064
CN - Cina 1.931
IT - Italia 1.141
IE - Irlanda 870
DE - Germania 783
FR - Francia 690
SE - Svezia 643
FI - Finlandia 507
UA - Ucraina 441
KR - Corea 426
SG - Singapore 368
GB - Regno Unito 331
AT - Austria 243
PL - Polonia 242
CA - Canada 233
VN - Vietnam 151
JP - Giappone 91
IN - India 86
AU - Australia 69
ES - Italia 63
ID - Indonesia 58
BR - Brasile 54
TW - Taiwan 43
NL - Olanda 42
TR - Turchia 42
BE - Belgio 41
HK - Hong Kong 37
RU - Federazione Russa 36
CH - Svizzera 29
IR - Iran 25
PH - Filippine 23
MX - Messico 22
SN - Senegal 20
GR - Grecia 16
MY - Malesia 16
NZ - Nuova Zelanda 15
TH - Thailandia 15
CO - Colombia 14
NO - Norvegia 14
UZ - Uzbekistan 14
PE - Perù 13
AR - Argentina 12
RO - Romania 12
EU - Europa 11
PT - Portogallo 11
HU - Ungheria 10
BY - Bielorussia 8
IQ - Iraq 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
EG - Egitto 7
BG - Bulgaria 6
CL - Cile 6
IL - Israele 6
PK - Pakistan 5
RS - Serbia 5
KE - Kenya 4
MA - Marocco 4
MK - Macedonia 4
NG - Nigeria 4
DZ - Algeria 3
EE - Estonia 3
JM - Giamaica 3
LT - Lituania 3
LU - Lussemburgo 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
ZA - Sudafrica 3
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
IM - Isola di Man 2
IS - Islanda 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
PS - Palestinian Territory 2
QA - Qatar 2
VE - Venezuela 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MC - Monaco 1
MM - Myanmar 1
MU - Mauritius 1
MZ - Mozambico 1
Totale 26.429
Città #
Ann Arbor 4.819
Beijing 1.309
Chandler 1.098
Dublin 858
Houston 579
Wilmington 492
Ashburn 457
Villeurbanne 419
Fairfield 370
Jacksonville 364
Princeton 351
Dearborn 331
Woodbridge 317
Medford 272
Singapore 246
Vienna 240
Nyköping 231
Warsaw 220
Seattle 209
Redwood City 201
Torino 182
Munich 150
Cambridge 128
Fremont 127
Milan 125
Boston 119
Pisa 111
Dong Ket 107
Montréal 104
Palaiseau 94
Grafing 84
Boardman 72
Hefei 57
Menlo Park 56
New York 53
Shanghai 53
Toronto 53
Verona 50
Nanjing 45
Guangzhou 44
Hangzhou 42
Kunming 41
Düsseldorf 40
Norwalk 39
Falls Church 36
Rome 31
Turin 31
Santa Clara 30
Los Angeles 29
San Diego 29
Brussels 28
Phoenix 28
Nanchang 27
Taipei 27
Helsinki 25
Tokyo 24
Mountain View 23
Des Moines 20
Jakarta 20
Lachine 20
London 20
Chengdu 19
Jinan 19
Central District 18
Changsha 18
Detroit 18
Padova 18
Pune 18
Wuhan 18
Istanbul 16
Ottawa 16
Silver Spring 16
Stockholm 16
Washington 16
Chongqing 14
Duncan 14
Frankfurt am Main 14
Lima 13
Madrid 13
Zhengzhou 13
Bologna 12
Edinburgh 12
San Francisco 12
Shenyang 12
Chicago 11
Hanoi 11
Hebei 11
Sydney 11
Fuzhou 10
Moscow 10
San Mateo 10
Trieste 10
Costa Mesa 9
Kuala Lumpur 9
São Paulo 9
Zurich 9
Amsterdam 8
Berlin 8
Catania 8
Montreal 8
Totale 16.314
Nome #
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial 748
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 428
Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes 423
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 414
Impact of Snacking Pattern on Overweight and Obesity Risk in A Cohort of 11-13-y Adolescents 399
Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy) 352
Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato survey, Italy. 347
Joint use of cardio-embolic and bleeding risk scorers in elderly patients with atrial fibrillation. 295
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. 282
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy 282
Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study 246
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort. 242
Direct costs of diabetic and non diabetic people: the population-based Turin study. 234
NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study 227
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. 226
The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study 222
Serum levels of heat shock protein 27 in patients with acute ischemic stroke 214
Activated protein C resistance in type I diabetes. 201
What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients 197
Association between serum heat shock proteins and anti-heat shock proteins levels with micro/macrovascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study 189
Effetti dello stress meccanico (stretch) combinato all’alto glucosio sulla proliferazione, l’apoptosi e la morfologia dei periciti retinici. 189
Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. 189
Albumin excretion rate is not increased in atherosclerotic patients with peripheral vascular disease. 188
Urinary exosomal microRNA signature in incipient diabetic nephropathy 188
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study 187
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study 186
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study 185
N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. 185
Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma 183
Silicone lymphadenopathy after silent Silicone breast implant rupture 181
Anticoagulant protein C activity in non-insulin-dependent diabetic patients with normoalbuminuria and microalbuminuria 180
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 179
Monocyte Chemoattractant Protein-1 (MCP-1) has direct prosclerotic effects in human mesangial cells 179
Apolipoprotein H is increased in type 2 diabetic patients with microalbuminuria. 179
Ruolo protettivo del recettore CB2 nella nefropatia diabetica sperimentale 178
Anticoagulant protein C in type II diabetic patients with and without microalbuminuria 177
MORTALITY OUTCOMES OF DIFFERENT SULFONYLUREA DRUGS. The results of a 14-year cohort study of type 2 diabetic patients 177
Protective role of cannabinoid receptor type-2 in a mouse model of diabetic nephropathy 174
Effetti dello stress meccanico (stretch) sulla proliferazione cellulare nei periciti retinici bovini in alto glucosio. 174
Effects of mechanical stress and high glucose on pericyte proliferation, apoptosis and contractile phenotype 174
Il sistema MCP-1/CCR2 nelle cellule mesangiali umane: modulazione da stretch e ruolo nell’espressione di ICAM-1 174
Espressione delle proteine dello slit DIAPHRAGM in animali diabetici knockout per il monocyte chemoattractant protein-1. 173
Urinary excretion of glycated albumin in insulin-dependent diabetic patients with micro- and macroalbuminuria. 172
Early life socioeconomic indicators and the risk of type 1 diabetes in children and young adults 169
Albumin excretion rate in non diabetic offspring of type 2 diabetic patients 169
The glucoregulatory and antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study. 166
Lipoprotein(a) after acute exercise in healthy subjects. 165
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes 165
Retinal heat shock protein 25 in early experimental diabetes 165
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study 164
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 164
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE 163
Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study 160
The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells 160
Increased QT interval dispersion predicts 15-years cardiovascular mortality in type 2 diabetic subjects. The population-based Casale Monferrato Study 160
High-normal blood pressure and impaired renal function. A prospective study in a population-based cohort. 160
Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. 159
Effect of CB2 Receptor Activation in Experimental Diabetic Nephropathy 158
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice 158
Trombomodulin is increased in microalbuminuric insulin dependent diabetic patients 158
Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the Eurodiab Prospective Complications Study 157
The Monocyte Chemoattractant Protein-1/Cognate CC Chemokine Receptor 2 System Affects Cell Motility in Cultured Human Podocytes 157
Effetti dello stress meccanico(stretch) combinato con l’alto glucosio sulla proliferazione, l’apoptosi e la morfologia dei periciti retinici. 157
Effects of mechanical stress (stretch) combined with high glucose on retinal pericyte replication, apoptosis and morphology. 157
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells 156
Increased retinal HSP27 expression in early experimental diabetes 156
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy. 154
Thrombomodulin levels in insulin-dependent diabetic patients with microalbuminuria 154
Heat shock protein expression in early diabetic nephropathy 154
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α 153
Increased levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria 153
Effects of CB1 Blockade In Experimental Diabetic Nephropathy 152
Serum glucose, insulin, C-peptide and plasma glucagon response to oral glucose after intravenous injection of different glucocorticoids at increasing doses in man 152
Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity. 151
Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. 151
PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria 151
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale 151
Electrocardiographic left ventricular hypertrophy in type 1 diabetes. Prevalence and relation to coronary heart disease and cardiovascular risk factors: The Eurodiab IDDM Complications Study 150
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. 150
Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy 149
Effects of mechanical stress (stretch) combined with high glucose on retinal pericyte replication, apoptosis and morphology. 149
N-terminal pro-brain natriuretic peptide and cardiovascular mortality in type 2 diabetes: the Casale Monferrato survey. 149
Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man 149
QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study 149
Coagulation inhibitors in type 2 diabetic patients with and without microalbuminuria 148
Microalbuminuria and plasma endothelin-1 in non insulin dependent diabetes mellitus 148
Heat shock protein expression in diabetic nephropathy 146
The MCP-1/CCR2 system in human mesangial cells: modulation by stretch and role in ICAM-1 expression 145
Lipoprotein(a) in non-insulin-dependent diabetic patients with normo- and microalbuminuria 145
Plasma beta-thromboglobulin and platelet factor 4 are not increased in insulin-dependent diabetic patients with microalbuminuria 144
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology 143
Microalbuminuria in insulin-dependent diabetes is associated with high levels of prothrombin fragment 1 + 2 143
Microalbuminuria in insulin-dependent diabetes is associated with monocyte procoagulant activity 143
Haemostatic alterations in microalbuminuric insulin dependent diabetic patient 141
The rs553668 polymorphism of ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study 141
Il blocco del recettore CB1 nella nefropatia diabetica sperimentale 138
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone 138
Lipoprotein(a) and insulin treatment in non insulin dependent diabetic patients 136
La dolce Vita. Per un Museo del Diabete. FONDAZIONE DIABETE TORINO - ONLUS 136
Coma nel diabetico 135
Totale 19.013
Categoria #
all - tutte 65.227
article - articoli 0
book - libri 0
conference - conferenze 16.010
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.830 0 0 652 399 685 1.161 486 208 229 424 775 811
2020/20212.832 651 97 138 93 190 138 175 89 291 202 105 663
2021/20225.951 587 467 512 731 456 499 630 558 404 99 424 584
2022/20233.786 554 195 58 285 337 970 394 292 353 59 229 60
2023/20241.537 180 223 70 86 98 203 47 195 17 102 113 203
2024/2025248 48 200 0 0 0 0 0 0 0 0 0 0
Totale 27.566